Description: With combined force of biomedical and clinical proteomics, NCI-Proteomics Program sets its quest to identify and characterize the protein signatures of human cancer cells and tissues and to apply proteomics technologies directly to patient diagnosis, toxicity monitoring, and therapeutic intervention.